NIMG-85. PBR28 PET-MRI IN GBM PATIENTS TREATED WITH IMMUNOTHERAPY OR SUSPECTED PSUEDOPROGRESSION

BACKGROUND: Increases in contrast enhancement due to treatment related inflammation creates a significant clinical conundrum for neuro-oncologists. Our goal was to use simultaneous PBR28 PET-MRI to measure TSPO, a marker of microglia activation as well glioma cells, in patients with glioblastoma (GB...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Main Authors: Chandra, Vyshak, Salcedo, Stephanie, Yen, Yi-Fen, Cardona, Jonathan, Beers, Andrew, Catana, Ciprian, Kalpathy-Cramer, Jayashree, Curry, William T, Gerstner, Elizabeth
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2017
Assuntos:
Abstracts
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692854/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.655
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares